AKT1 and plasmacytoma: In another study with mouse plasmacytomas, i.e., tumors of mature plasma cells, EEF1A2 knockdown expression decreased IL-6-mediated activation of STAT3 and AKT pathways, leading to a decrease in proliferation of plasmacytomas (PCT) cell lines with delayed cell-cycle entry [6].